# Progress Note 05 — Preventive Visit

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

- Patient: Julius Caesar (real historical name used in a fictional teaching record)
- Synthetic MRN: HR-AC001-SYN
- Date: 2026-10-06
- Fictional facility: St. Posthumous Health Center
- Fictional author: Lucius Fairbanks-Okonkwo, MD
- Calendar frame: modern shifted

- Visit type: Preventive Visit
- Services: CPT 99396 (periodic preventive medicine, established patient, age 40 to 64) with CPT 99497 (advance care planning) on the same day; vaccine administration billed separately

## Chief complaint

Adult preventive visit; no new complaints. **S**

## History of present illness

Julius Caesar returns for his adult preventive visit three weeks after his four-week review. The cold has gone. He has had no seizure or spell since starting levetiracetam seven weeks ago and has missed no doses. He takes lisinopril 10 mg, amlodipine 5 mg (added three weeks ago), atorvastatin 80 mg, and aspirin 81 mg without side effects; his home blood pressure readings have been 122 to 132 over 76 to 82. He is sleeping about seven hours a night, has a driver for all journeys, and rides only with a companion. He completed the health risk assessment before the visit. **S**

| Element | Detail |
|---|---|
| Visit | Adult preventive visit, age 54 |
| Active conditions | Focal epilepsy with a vascular cause; chronic left temporal infarct; hypertension; hyperlipidemia |
| Medicines | Levetiracetam 500 mg twice daily, lisinopril 10 mg, amlodipine 5 mg, atorvastatin 80 mg, aspirin 81 mg |
| Since the last visit | Cold resolved; no seizure; home blood pressure 122 to 132 over 76 to 82 |
| Functional status | Independent; working full days with less evening work |

## Health risk assessment

Completed by the patient before the visit and reviewed during the visit. **S**

| Domain | Finding |
|---|---|
| Self-rated health | Good |
| Psychosocial | Demanding public work, supported by his staff; married; no money worries |
| Behavioral | Never smoker; a glass of wine once or twice a week (AUDIT-C 1); no other drug use; walks daily and rides at weekends with a companion |
| Nutrition | Mediterranean-style diet since the last visits; less salt |
| Activities of daily living | Independent in all |
| Instrumental activities of daily living | Manages his own medicines with a weekly pill box |
| Home safety | Smoke detectors working; showers rather than baths; no firearms |
| Sleep | About seven hours a night; vivid dreams less frequent |
| Driving | Not driving; a driver for all journeys |
| Hearing and vision | No hearing concern; reading glasses; no eye examination for three years |
| Falls | No falls apart from the collapse before his first visit |

## Review of systems

| System | Result | Finding |
|---|---|---|
| Constitutional | Negative | Weight stable; no fever or night sweats |
| Eyes | Negative | No double or blurred vision |
| Ears, nose, mouth, and throat | Negative | Cold resolved; tongue healed |
| Cardiovascular | Negative | No chest pain, palpitations, or ankle swelling |
| Respiratory | Negative | No cough or breathlessness |
| Gastrointestinal | Negative | No indigestion, bleeding, or change in bowel habit |
| Genitourinary | Negative | No urinary symptoms |
| Musculoskeletal | Negative | No muscle aches on atorvastatin |
| Integumentary | Negative | No rash or easy bruising |
| Neurological | Negative | No spell, weakness, numbness, or speech change; occasional mild tension headaches |
| Psychiatric | Negative | Mood steady; PHQ-2 score 0; no irritability now |

11 systems reviewed. **S**

## Current medications

- Lisinopril 10 mg oral tablet, one tablet by mouth daily **S**
- Levetiracetam 500 mg oral tablet, one tablet by mouth twice daily **S**
- Atorvastatin 80 mg oral tablet, one tablet by mouth at bedtime **S**
- Aspirin 81 mg delayed-release tablet, one tablet by mouth daily **S**
- Amlodipine 5 mg oral tablet, one tablet by mouth daily **S**

## Allergies

- No known allergy **S**

## Objective

BP 128/80 mmHg; pulse 66 bpm; respirations 14/min; temperature 36.6 °C; oxygen saturation 98% on room air; weight 75.2 kg; BMI 22.7 kg/m². All vital signs are synthetic.

PHQ-2: 0; AUDIT-C: 1. All results are synthetic.

## Change since baseline

- AUDIT-C: 1 at baseline, 1 at this visit **S**

## Immunizations given today

- Influenza vaccine, 2026-2027 season **S**
- Recombinant zoster vaccine, dose 1 of 2 **S**
- Pneumococcal conjugate vaccine (PCV20), single dose **S**

## Physical examination

| System | Finding |
|---|---|
| Constitutional | Well; BMI 22.7 |
| Eyes | Pupils equal and reactive; fundi show mild arteriolar narrowing |
| Ears, nose, and throat | Normal |
| Neck | No bruit; no thyroid enlargement or nodes |
| Cardiovascular | Regular rhythm; no murmur; no edema |
| Respiratory | Clear |
| Abdomen | Soft, non-tender; no aortic pulsation felt |
| Musculoskeletal | Normal range of motion |
| Neurological | No focal deficit; normal gait |
| Skin | No suspicious lesions |
| Psychiatric | Calm and engaged |

All examination findings are synthetic. **S**

## Assessment and plan

1. **Adult preventive visit completed**. Health risk assessment reviewed and a written prevention plan given. Depression screen negative (PHQ-2 0). AUDIT-C 1. Blood pressure 128/80 mmHg, close to target. **S**
   - Next preventive visit in one year.
2. **Focal epilepsy on levetiracetam** (G40.209). Seizure-free for seven weeks; no side effects. **S**
   - Continue levetiracetam 500 mg twice daily.
   - Ten-week review as planned.
3. **Chronic left temporal cortical infarct** (I69.398). On aspirin, atorvastatin, and two blood pressure medicines; no new symptoms. **S**
   - Lipid panel at the ten-week review.

## Personalized prevention plan

A written copy was given to the patient. **S**

| Service | Status | Detail |
|---|---|---|
| Influenza vaccine, 2026-2027 | Completed today | Inactivated vaccine given today |
| Pneumococcal vaccine | Completed today | Recommended for all adults from age 50; PCV20 given today; no further pneumococcal dose needed |
| Recombinant zoster vaccine | Completed today | Dose 1 of 2 today; dose 2 in two to six months |
| COVID-19 vaccine, 2026-2027 | Due | Offered; he will have it at his pharmacy next week, away from today's three vaccines |
| Tetanus, diphtheria, and pertussis booster | Up to date | Tdap about seven years ago; next due in about three years |
| Hepatitis B vaccine | Up to date | He reports a completed series as a young army officer; record requested |
| Hepatitis C, hepatitis B, and HIV screening | Ordered | One-time screening for adults; no earlier result on record; drawn today with his consent |
| Blood pressure | Completed today | 128/80 mmHg on two medicines; target below 130/80 mmHg |
| Cholesterol | Up to date | On atorvastatin 80 mg since the infarct was found; lipid panel due at the ten-week review |
| Diabetes screening | Up to date | HbA1c 5.6 percent at intake; repeat in three years, or yearly if it reaches 5.7 |
| Colorectal cancer screening | Ordered | Never screened; recommended from 45. He chose colonoscopy, which is booked; aspirin can be continued for the procedure |
| Prostate cancer screening | Not indicated | Shared decision-making about PSA testing begins at 55; to be discussed at next year's visit |
| Depression screening | Completed today | PHQ-2 score 0 |
| Unhealthy alcohol use screening | Completed today | AUDIT-C 1 |
| Tobacco use | Completed today | Never smoker |
| Lung cancer and abdominal aortic aneurysm screening | Not indicated | Never smoker; under the starting age for aneurysm screening |
| Eye examination | Due | None for three years; fundi show mild hypertensive narrowing; he will book an optometrist |

## Advance care planning

Voluntary advance care planning discussion of about 20 minutes, with his consent, prompted by the finding of an old infarct on his scan. He named a health care agent and completed a health care power of attorney form; the agent is recorded in the chart and is not named here. He said he would want full treatment for any new stroke or prolonged seizure, including thrombolysis or thrombectomy if offered, and wants his agent and his neurologist told at once if he is admitted. He chose not to record other treatment preferences today. The plan will be revisited yearly or after any serious illness. **S**

## Guideline basis

- Medicare Preventive Services reference: visit templates, screening cascades, and documentation elements (2026), Aether Forge
- USPSTF A and B Recommendations (2026), U.S. Preventive Services Task Force
- Adult Immunization Schedule by Age (2026), Centers for Disease Control and Prevention

## Follow-up

- Hepatitis C, hepatitis B, and HIV results by message. Colonoscopy as booked. Second zoster dose in two to six months. Ten-week chronic-care review in three weeks. Next preventive visit in one year. **S**
- Next scheduled visit 2026-10-27: ten-week review: seizure control, lipids on atorvastatin, blood pressure, and driving and safety. **S**
